Unfortunately nothing so admirable. Though I'ld like to (one day) get something set up in Brazil to help those with MPS disorders in some way haven't progressed.
My interest comes from investments in TKT, BMRN and FOLD. So I follow Genzyme, Shire, PLX and to a lesser degree PTC, FoldRx and a couple of other obscure biotechs who are working in those areas.
Market Data 
Markets 
AI
